Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 Active Not Recruiting Phase 2 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0088881 (Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01064479Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckTreatment